Cargando…
Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906457/ https://www.ncbi.nlm.nih.gov/pubmed/35235414 http://dx.doi.org/10.1200/PO.21.00286 |
| _version_ | 1784665406308352000 |
|---|---|
| author | Henderson, Jacob J. Das, Anirban Morgenstern, Daniel A. Sudhaman, Sumedha Bianchi, Vanessa Chung, Jill Negm, Logine Edwards, Melissa Kram, David E. Osborn, Michael Hawkins, Cynthia Bouffet, Eric Cho, Yoon-Jae Tabori, Uri |
| author_facet | Henderson, Jacob J. Das, Anirban Morgenstern, Daniel A. Sudhaman, Sumedha Bianchi, Vanessa Chung, Jill Negm, Logine Edwards, Melissa Kram, David E. Osborn, Michael Hawkins, Cynthia Bouffet, Eric Cho, Yoon-Jae Tabori, Uri |
| author_sort | Henderson, Jacob J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8906457 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89064572022-03-10 Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study Henderson, Jacob J. Das, Anirban Morgenstern, Daniel A. Sudhaman, Sumedha Bianchi, Vanessa Chung, Jill Negm, Logine Edwards, Melissa Kram, David E. Osborn, Michael Hawkins, Cynthia Bouffet, Eric Cho, Yoon-Jae Tabori, Uri JCO Precis Oncol Case Reports Wolters Kluwer Health 2022-03-02 /pmc/articles/PMC8906457/ /pubmed/35235414 http://dx.doi.org/10.1200/PO.21.00286 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Case Reports Henderson, Jacob J. Das, Anirban Morgenstern, Daniel A. Sudhaman, Sumedha Bianchi, Vanessa Chung, Jill Negm, Logine Edwards, Melissa Kram, David E. Osborn, Michael Hawkins, Cynthia Bouffet, Eric Cho, Yoon-Jae Tabori, Uri Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study |
| title | Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study |
| title_full | Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study |
| title_fullStr | Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study |
| title_full_unstemmed | Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study |
| title_short | Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study |
| title_sort | immune checkpoint inhibition as single therapy for synchronous cancers exhibiting hypermutation: an irrdc study |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906457/ https://www.ncbi.nlm.nih.gov/pubmed/35235414 http://dx.doi.org/10.1200/PO.21.00286 |
| work_keys_str_mv | AT hendersonjacobj immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT dasanirban immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT morgensterndaniela immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT sudhamansumedha immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT bianchivanessa immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT chungjill immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT negmlogine immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT edwardsmelissa immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT kramdavide immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT osbornmichael immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT hawkinscynthia immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT bouffeteric immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT choyoonjae immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy AT taboriuri immunecheckpointinhibitionassingletherapyforsynchronouscancersexhibitinghypermutationanirrdcstudy |